Survival in people with type 2 diabetes as a function of HbA(1c).
Balkau
Beverley
B
Epidemiology of Diabetes, Obesity and Chronic Kidney Disease over the Lifecourse, CESP Centre for Research in Epidemiology and Population Health, U1018, Inserm, F-94807, Villejuif, France. beverley.balkau@inserm.fr
Simon
Dominique
D
D015415:Biomarkers / Q000097:blood; D002423:Cause of Death; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology / Q000401:mortality; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D015415:Biomarkers; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin